A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes

Conditions

Type 1 Diabetes

What is the purpose of this trial?

The goal of the proposed pilot study is to determine whether glucose control can be improved with Bydureon treatment in patients with type I diabetes (T1D)


Participation Guidelines

Age:
18 Years - 60 Years
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
Juvenile Diabetes Research Foundation International
Dates:
10/08/2013
Last Updated:
Study HIC#:
1307012371